IMRT

Stereotactic radiotherapy for oligometastases: a prognostic model for survival

 Aim: to identify subsets of patients that benefit in terms of overall survival  2005 – 2011: 309 patients ≤ 5 mets  SBRT (n = 209) or SRS (n = 107)  Median delivered BED = 60 Gy (range: 26 – 112 Gy)

 Median follow-up = 12 months (range: 1 – 84 months)

De Vin et al, Ann Oncol 2014

11

27-1-2016